Page 54 - Read Online
P. 54

Page 10 of 11                                  Kepka. J Cancer Metastasis Treat 2019;5:53  I  http://dx.doi.org/10.20517/2394-4722.2018.114

                   from small-cell lung cancer. Strahlenther Oncol 2018;194:98-106.
               13.  Bernhardt D, Adeberg S, Bozorgmehr F, et al. Outcome and prognostic factors in patients with brain metastases from small-cell lung
                   cancer treated with whole brain radiotherapy. J Neurooncol 2017;134:205-12.
               14.  Bernhardt D, König L, Aufderstrasse S, Krisam J, Hoerner-Rieber J, et al. Generation of a new disease-specific prognostic score for
                   patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy (BMS-Score) and validation of two
                   other indices. Clin Lung Cancer 2018;19:340-5.
               15.  Grossi F, Scolaro T, Tixi L, Loprevite M, Ardizzoni A. The role of systemic chemotherapy in the treatment of brain metastases from
                   small-cell lung cancer. Crit Rev Oncol Hematol 2001;37:61-7.
               16.  Seute T, Leffers P, Wilmink JT, ten Velde GP, Twijnstra A. Response of asymptomatic brain metastases from small-cell lung cancer to
                   systemic first-line chemotherapy. J Clin Oncol 2006;24:2079-83.
               17.  Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, et al. Postoperative stereotactic radiosurgery compared with whole
                   brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial.
                   Lancet Oncol 2017;18:1049-60.
               18.  Kepka L, Tyc-Szczepaniak, Bujko K, Olszyna-Serementa M, Michalski W, et al. Stereotactic radiotherapy of the tumor bed compared
                   to whole brain radiotherapy after surgery of single brain metastasis: results from a randomized trial. Radiother Oncol 2016;121:217-24.
               19.  Slotman B, Faivre-Finn C, Kramer G, Postmus B, Senan S, Prophylactic cranial irradiation in small-cell lung cancer. N Engl J Med
                   2007;357:1978.
               20.  Davey P, Ennis M, Aviv R. Prophylactic cranial irradiation (PCI). Still a no-brainer? Lung Cancer 2015;89:4-7.
               21.  National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer (Version 1.2019).
               22.  Farell MJ, Yahya JB, Degnin C, Chen Y, Holland JM, et al. Prophylactic cranial irradiation for limited-stage small cell lung cancer: A
                   survey of US radiation oncologists on current practice patterns. Clin Lung Cancer 2019;20:13-9.
               23.  Putora PM, Glatzer M, Belderbos J, Besse B, Blackhall F, et al. Prophylactic cranial irradiation in stage IV small cell lung cancer:
                   Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol 2019;133;163-6.
               24.  Manapov F, Klautke G, Fietkau R. Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited
                   disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. J Thoracic Oncol
                   2008;3:652-5.
               25.  Chu X, Yang X, Zhu Z. Prevalence and risk factors of brain metastases in limited stage small cell lung cancer immediately before
                   prophylactic cranial irradiation. J Thorac Oncol 2018;10:S436.
               26.  Suwinski R, Lee SP, Withers HR. Dose-response relationship for prophylactic cranial irradiation in small cell lung cancer. Int J Radiat
                   Oncol Biol Phys 1998;40:797-806.
               27.  Takahashi T, Yamanaka T, Seto T, Harada H, Nokihara H, et al. Prophylactic cranial irradiation versus observation in patients with
                   extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2017;18:663-71.
               28.  Puglisi M, Dolly S, Faria A, Myerson JS, Popat S, et al. Treatment options for small cell lung cancer – do we have more choice? Br J
                   Cancer 2010;102:629-38.
               29.  Reveiz L, Rueda JR, Cardona AF. Chemotherapy for brain metastases from small cell lung cancer. Cochrane Database Syst Rev
                   2012;6:CD007464.
               30.  Neuhaus T, Ko Y, Muller RP, Grabenbauer GG, Hedde JP, et al. A phase III trial of topotecan and whole brain radiation therapy for
                   patients with CNS-metastases due to lung cancer. Br J Cancer 2009;100:291-7.
               31.  Liu M, Zhou Y, Han Q, Gao T, Luo Z, Wang W. Whole brain radiotherapy concomitant or sequential Vm26/DDP in treating small cell
                   lung cancer patients with brain metastases. Chinese-German Journal of Clinical Oncology 2010;9:17-21.
               32.  Komosinska K, Kepka L, Niwinska A, Pietrzak L, Wierzchowski M, et al. Prospective evaluation of the palliative effect of whole-brain
                   radiotherapy in patients with brain metastases and poor performance status. Acta Oncol 2010;49:382-8.
               33.  Mulvenna  P,  Nankivell  M,  Barton  R,  Faivre-Finn  C,  Wilson  P,  et  al.  Dexamethasone  and  supportive  care  with  or  without  whole
                   brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic
                   radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet 2016;388:2004-14.
               34.  Mazure B, Guest N, Letcher A, et al. Should stereotactic radiosurgery be considered for salvage of intracranial recurrence in small cell
                   lung cancer? J Thoracic Oncol 2018;13:S436.
               35.  Bernhardt D, Bozorgmehr F, Adeberg S, Opfermann N, von Eiff D, et al. Outcome in patients with small cell lung cancer re-irradiated
                   for brain metastases after prior prophylactic cranial irradiation. Lung Cancer 2016;101:76-81.
               36.  Harris S, Chan MD, Lovato JF, Ellis TL, Tatter SB, et al. Gamma knife stereotactic radiosurgery as salvage therapy after failure of
                   whole-brain radiotherapy in patients with small cell lung cancer. Int J Radiat Oncol Biol Phys 2012;83:e53-9.
               37.  Rava P, Sioshansi S, DiPetrillo T, Cosgrove R, Melhus C, et al. Local recurrence and survival following stereotactic radiosurgery for
                   brain metastases from small cell lung cancer. Pract Radiat Oncol 2015;5:e37-44.
               38.  Nakazaki K, Higuchi Y, Nagano O, and Serizawa T. Efficacy and limitations of salvage gamma knife radiosurgery for brain metastases
                   of small-cell lung cancer after whole-brain radiotherapy. Acta Neurochir 2013;155:107-14.
               39.  Olson AC, Wegner RE, Rwigema JC, Heron DE, Burton SA, et al. Clinical outcomes of reirradiation of brain metastases from small cell
                   lung cancer with cyberknife stereotactic radiosurgery. J Cancer Res Ther 2012;8:411-6.
               40.  Wegner RE, Olson AC, Kondziolka D, Niranjan A, Lundsford LD, et al. Stereotactic radiosurgery for patients with brain metastases
                   from small cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81:e21-7.
               41.  Yomo S, Hayashi M. Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A
                   retrospective analysis of 70 consecutive patients. BMC Cancer 2015;15:95.
   49   50   51   52   53   54   55   56   57   58   59